Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Tolerance of Meloxicam Eye Drops in Healthy Volunteers
NCT04322175Phase 1Unknown
- Sponsor
- Beijing Tongren Hospital
- Start
- Dec 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of meloxicam in ocular inflammation (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoints: Concentration of drug prototype-meloxicam in tears at 2 days, Intraocular pressure at 1 day and 1 more. Status: unknown.
02
Drugs
meloxicam
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT04322175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04322175.